This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biotech Calendar: Key Dates for March

BOSTON ( TheStreet) -- A calendar of important, potentially stock-moving biotech events for March:

March 2-3

RBC Capital Markets Healthcare Conference

March 4

Bristol-Myers Squibb investor/analyst meeting (BMY)

March 5-7

ASCO Genitourinary Cancers Symposium: Dendreon (DNDN) presenting updated data from the phase III study of Provenge

March 8-11

Cowen & Co Healthcare Conference

March 9

FDA advisory panel meets to discuss InterMune's (ITMN) pirfenidone for the treatment of idiopathic pulmonary fibrosis. The FDA's briefing documents for this meeting likely available on March 5 or March 8.

March 12

FDA approval decision date for exenatide once weekly for diabetes, developed by Amylin Pharmaceuticals (AMLN) and Alkermes (ALKS - Get Report), co-marketed by Eli Lilly (LLY).

March 14-16

American College of Cardiology annual meeting

March 19

Viropharma (VPHM) investor/analyst meeting
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ALKS $37.80 0.48%
DNDN $0.06 -6.02%
ITMN $73.89 -0.03%
SLXP $172.81 0.09%
GNVC $0.69 -18.73%


Chart of I:DJI
DOW 17,588.87 -71.84 -0.41%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs